-
DE
A chondroprotective agent is a substance that protects joint cartilage, supports its regeneration, and slows cartilage breakdown. It is commonly used in osteoarthritis.
A chondroprotective agent is a substance that protects joint cartilage, supports its regeneration, and slows cartilage breakdown. It is commonly used in osteoarthritis.
A chondroprotective agent (also called chondroprotectant) is a substance or preparation that protects joint cartilage, supports its regeneration, and slows the progressive breakdown of cartilage tissue. The term is derived from the Greek word chondros (cartilage) and the Latin protegere (to protect). Chondroprotective agents are primarily used in the treatment and prevention of degenerative joint diseases such as osteoarthritis.
Chondroprotective agents act on multiple levels within joint cartilage and synovial fluid (the lubricating fluid of the joint). Key mechanisms include:
Glucosamine is a natural amino sugar that is a structural component of cartilage. It is derived from crustacean shells or produced synthetically, and is believed to stimulate cartilage matrix production and exert anti-inflammatory effects.
Chondroitin sulfate is a glycosaminoglycan naturally found in cartilage. It supports the water-retaining capacity of cartilage, inhibits cartilage-degrading enzymes, and helps stabilize the cartilage structure.
Hyaluronic acid is a key component of synovial fluid, providing its lubricating and shock-absorbing properties. It is often administered directly into the joint (intra-articular injection) to improve joint function.
Collagen hydrolysate (also known as hydrolyzed collagen) supplies the body with amino acids needed for cartilage collagen synthesis. Taken orally, it may help support the cartilage matrix.
Extracts from avocado and soybean have demonstrated anti-inflammatory and cartilage-protective properties in clinical studies. In several European countries, ASU preparations are approved as prescription medications for osteoarthritis.
Chondroprotective agents are mainly used for:
Chondroprotective agents are available in several forms:
The scientific evidence for chondroprotective agents is mixed. Some studies on glucosamine and chondroitin sulfate show moderate pain relief and improved joint function in osteoarthritis patients, particularly in those with moderate to severe symptoms. The European Medicines Agency (EMA) has approved both chondroitin sulfate and glucosamine as medicinal products for the treatment of knee osteoarthritis. Other studies, including the large-scale GAIT trial, produced less conclusive results. As a rule, chondroprotective agents work slowly and over the long term and are classified as SYSADOA (Slow-Acting Drugs in Osteoarthritis). They are not a replacement for other therapeutic measures such as physiotherapy or weight management.
Chondroprotective agents are generally well tolerated. Possible side effects include:
Individuals with a shellfish allergy should choose plant-based or synthetic glucosamine sources. Patients with diabetes should monitor blood glucose levels carefully, as glucosamine may theoretically influence insulin sensitivity.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.